Medical Company Announces Promising Data From Phase III Parkinson's Study
Annovis Bio Announces Promising Data from Phase III Parkinson's Study.
Disclaimer: This article is for informational purposes only and is not intended to provide medical advice. The insights shared in this article are based on recent data announcements by Annovis Bio Inc. (NYSE: ANVS).
Real-time information is available daily at https://stockregion.net